These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 8903477)
1. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins. Bolognesi A; Tazzari PL; Olivieri F; Polito L; Falini B; Stirpe F Int J Cancer; 1996 Nov; 68(3):349-55. PubMed ID: 8903477 [TBL] [Abstract][Full Text] [Related]
2. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199 [TBL] [Abstract][Full Text] [Related]
4. Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. Battelli MG; Polito L; Bolognesi A; Lafleur L; Fradet Y; Stirpe F Int J Cancer; 1996 Feb; 65(4):485-90. PubMed ID: 8621232 [TBL] [Abstract][Full Text] [Related]
5. Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies. Sforzini S; Bolognesi A; Meazza R; Marciano S; Tazzari PL; Stein H; Stirpe F; Ferrini S J Hematother; 1995 Oct; 4(5):429-32. PubMed ID: 8581380 [TBL] [Abstract][Full Text] [Related]
6. High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins. Battelli MG; Montacuti V; Stirpe F Exp Cell Res; 1992 Jul; 201(1):109-12. PubMed ID: 1612115 [TBL] [Abstract][Full Text] [Related]
7. Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies. Sforzini S; de Totero D; Gaggero A; Ippoliti R; Glennie MJ; Canevari S; Stein H; Ferrini S Br J Haematol; 1998 Sep; 102(4):1061-8. PubMed ID: 9734659 [TBL] [Abstract][Full Text] [Related]
8. A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies. Bolognesi A; Tazzari PL; Tassi C; Gromo G; Gobbi M; Stirpe F Clin Exp Immunol; 1992 Sep; 89(3):341-6. PubMed ID: 1516253 [TBL] [Abstract][Full Text] [Related]
9. Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation. Tazzari PL; Zhang S; Chen Q; Sforzini S; Bolognesi A; Stirpe F; Xie H; Moretta A; Ferrini S Br J Cancer; 1993 Jun; 67(6):1248-53. PubMed ID: 8512810 [TBL] [Abstract][Full Text] [Related]
10. In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins. Bolognesi A; Polito L; Tazzari PL; Lemoli RM; Lubelli C; Fogli M; Boon L; de Boer M; Stirpe F Br J Haematol; 2000 Aug; 110(2):351-61. PubMed ID: 10971392 [TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F Haematologica; 1999 Nov; 84(11):988-95. PubMed ID: 10553158 [TBL] [Abstract][Full Text] [Related]
12. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography. Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254 [TBL] [Abstract][Full Text] [Related]
13. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6. Gasperi-Campani A; Zoli W; Volpi A; Roncuzzi L; Amadori D Anticancer Res; 1991; 11(2):1007-11. PubMed ID: 2064307 [TBL] [Abstract][Full Text] [Related]
15. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation. Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101 [TBL] [Abstract][Full Text] [Related]
18. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin. Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-human T cell antibody and PAP-s conjugate--preparation and selective cytotoxic properties on leukemic cell. Chu JY; Yang AD; Wang BM; Hu Z; Zhu XM; Zhang HJ; Qu JH; Luo LY; Guo R; Shi LR J Tongji Med Univ; 1990; 10(1):15-8. PubMed ID: 2348483 [TBL] [Abstract][Full Text] [Related]
20. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]